PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece.\', \'Infectious Diseases Division, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/bcp.14800
?:hasPublicationType
?:journal
  • British journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33684969
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.543
?:rankingScore_hIndex
  • 126
is ?:relation_isRelatedTo_publication of
?:title
  • Intestinal SGLT1 as a therapeutic target in COVID-19-related diabetes: A \'two-edged sword\' hypothesis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all